Amyloidosis Modifier Genes in the Less Amyloidogenic A/J Mouse Strain

Laboratory Investigation

Volumn 83, Issue 11, 2003, Pages 1605-1613

  Guo, Zhanjun ^a,b   Mori, Masayuki ^a   Fu, Xiaoying ^a   Yao, Junjie ^a   Xing, Yanming ^a   Korenaga, Tatsumi ^a   Li, Guixin ^a   Matsushita, Takatoshi ^c   Hosokawa, Masanori ^d   Higuchi, Keiichi ^a,b  

^a SHINSHU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d INSTITUTE FOR DEVELOPMENTAL RESEARCH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A2; PERLECAN; PHOSPHOLIPASE A2; SECRETORY PHOSPHOLIPASE A2 GROUP II; UNCLASSIFIED DRUG;

AGE; ALLELE; AMYLOIDOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACKCROSSING; CHROMOSOME 19; CHROMOSOME 4; CONTROLLED STUDY; DISEASE MODEL; DISEASE SEVERITY; GENE IDENTIFICATION; GENETIC ANALYSIS; GENETIC SCREENING; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; TELOMERE;

AMYLOID; AMYLOIDOSIS; ANIMALS; APOLIPOPROTEIN A-II; CHIMERA; CHROMOSOME MAPPING; FEMALE; GENES, REGULATOR; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HEPARAN SULFATE PROTEOGLYCANS; INBREEDING; LIVER; MALE; MICE; MICE, INBRED STRAINS; PHOSPHOLIPASES A; SPECIES SPECIFICITY;

EID: 10744228314     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.LAB.0000098426.35057.73     Document Type: Article

References (41)

1. Baba S, Masago SA, Takahashi T, Kasama T, Sugimura H, Tsugane S, Tsutsui Y, and Shirasawa H (1995). A novel allelic variant of serum amyloid A, SAA1 gamma: Genomic evidence, evolution, frequency, and implication as a risk factor for reactive systemic AA-amyloidosis. Hum Mol Genet 4:1083-1087.
2. Benson MD, Liepnieks JJ, Yazaki M, Yamashita T, Hamidi Asl K, Guenther B, and Kluve-Beckerman B (2001). A new human hereditary amyloidosis: The result of a stop-codon mutation in the apolipoprotein All gene. Genomics 72:272-277.
3. Bowton DL, Seeds MC, Fasano MB, Goldsmith B, and Bass DA (1997). Phospholipase A2 and arachidonate increase in bronchoalveolar lavage fluid after inhaled antigen challenge in asthmatics. Am J Respir Crit Care Med 155:421-425.
4. Carlson GA, Kingsbury DT, Goodman PA, Coleman S, Marshall ST, DeArmond S, Westaway D, and Prusiner SB (1986). Linkage of prion protein and scrapie incubation time genes. Cell 46:503-511.
5. Castillo GM, Ngo C, Cummings J, Wight TN, and Snow AD (1997). Perlecan binds to the beta-amyloid proteins (A beta) of Alzheimer's disease, accelerates A beta fibril formation, and maintains A beta fibril stability. J Neurochem 69:2452-2465.
6. Chai CK and Lerner C (1985). The inheritance of spontaneous amyloidosis development in mice: A model for hereditary threshold metabolic disorders. Am J Med Genet 22:49-58.
7. Glenner GG (1980). Amyloid deposits and amyloidosis: The beta-fibrilloses. N Engl J Med 302:1283-1292.
8. Higuchi K, Kitado H, Kitagawa K, Kogishi K, Naki H, and Takeda T (1993). Development of congenic strains of mice carrying amyloidogenic apolipoprotein A-II (Apoa2c): Apoa2c reduces the plasma level and the size of high density lipoprotein. FFBS Lett 317:207-210.
9. Higuchi K, Kitagawa K, Naiki H, Hanada K, Hosokawa M, and Takeda T (1991a). Polymorphism of apolipoprotein A-II (apoA-II) among inbred strains of mice: Relationship between the molecular type of apoA-II and mouse senile amyloidosis. Biochem J 279:427-433.
10. Higuchi K, Matsumura A, Honma A, Takeshita S, Hashimoto K, Hosokawa M, Yasuhira K, and Takeda T (1983). Systemic senile amyloid in senescence-accelerated mice: A unique fibril protein demonstrated in tissues from various organs by the unlabeled immunoperoxidase method. Lab Invest 48:231-240.
11. Higuchi K, Naiki H, Kitagawa K, Hosokawa M, and Taketa T (1991b). Mouse senile amyloidosis: ASSAM amyloidosis in mice presents universally as a systemic age-associated amyloidosis. Virchows Arch B Cell Pathol Incl Mol Pathol 60:231-238.
12. Higuchi K, Yonezu T, Kogishi K, Matsumura A, Takeshita S, Higuchi K, Kohno A, Matsushita M, Hosokawa M, and Takeda T (1986). Purification and characterization of a senile amyloid-related antigenic substance (apoSASSAM) from mouse serum: apoSASSAM is an apoA-II apolipoprotein of mouse high density lipoproteins. J Biol Chem 261:12834-12840.
13. Hurt-Camejo E, Andersen S, Standal R, Rosengren B, Sartipy P, Stadberg E, and Johansen B (1997). Localization of nonpancreatic secretory phospholipase A2 in normal and atherosclerotic arteries: Activity of the isolated enzyme on low-density lipoproteins. Arterioscler Thromb Vasc Biol 17:300-309.
14. Kennedy BP, Payette P, Mudgett J, Vadas P, Pruzanski W, Kwan M, Tang C, Rancourt DE, and Cromlish WA (1995). A natural disruption of the secretory group II phospholipase A2 gene in inbred mouse strains. J Biol Chem 270:22378-22385.
15. Kisilevsky R, Lemieux LJ, Fraser PE, Kong X, Hultin PG, and Szarek WA (1995). Arresting amyloidosis in vivo using small-molecule anionic sulphonates or sulphates: Implications for Alzheimer's disease. Nat Med 1:143-148.
16. Kitagawa K, Naiki H, Takeda T, and Higuchi K (1994). Age-associated decreases in the messenger ribonucleic acid level and rate of synthesis of apolipoprotein A-II in murine senile amyloidosis. Lab Invest 70:565-5711.
17. Koch KM (1992). Dialysis-related amyloidosis. Kidney Int 41:1416-1429.
18. Lander E and Kruglyak L (1995). Genetic dissection of complex traits: Guidelines for interpreting and reporting linkage results. Nat Genet 11:241-247.
19. Lyon AW, Narindrasorasak S, Young ID, Anastassiades T, Couchman JR, McCarthy KJ, and Kisilevsky R (1991). Co-deposition of basement membrane components during the induction of murine splenic AA amyloid. Lab Invest 64:785-790.
20. MacPhee M, Chepenik KP, Liddell RA, Nelson KK, Siracusa LD, and Buchberg AM (1995). The secretory phospholipase A2 gene is a candidate for the Mom1 locus, a major modifier of ApcMin-induced intestinal neoplasia. Cell 81:957-966.
21. Manly KF (1993). A Macintosh program for storage and analysis of experimental genetic mapping data. Mamm Genome 4:303-313.
22. Mehrabian M, Qiao JH, Hyman R, Ruddle D, Laughton C, and Lusis AJ (1993). Influence of the apoA-II gene locus on HDL levels and fatty streak development in mice. Arterioscler Thromb 13:1-10.
23. Naiki H, Higuchi K, Yonezu T, Hosokawa M, and Takeda T (1988). Metabolism of senile amyloid precursor and amyloidogenesis: Age-related acceleration of apolipoprotein A-II clearance in the senescence accelerated mouse. Am J Pathol 130:579-587.
24. Nakano T, Ohara O, Teraoka H, and Arita H (1990). Group 11 phospholipase A2 mRNA synthesis is stimulated by two distinct mechanisms in rat vascular smooth muscle cells. FEBS Lett 261:171-174.
25. Pruzanski W, de Beer FC, de Beer MC, Stefanski E, and Vadas P (1995). Serum amyloid A protein enhances the activity of secretory non-pancreatic phospholipase A2. Biochem J 309:461-464.
26. Pruzanski W, Stefanski E, de Beer FC, de Beer MC, Vadas P, Ravandi A, and Kuksis A (1998). Lipoproteins are substrates for human secretory group IIA phospholipase A2: Preferential hydrolysis of acute phase HDL. J Lipid Res 39:2150-2160.
27. Risch NJ (2000). Searching for genetic determinants in the new millennium. Nature 405:847-856.
28. Sartipy P, Johansen B, Camejo G, Rosengren B, Bondjers G, and Hurt-Camejo E (1996). Binding of human phospholipase A2 type II to proteoglycans: Differential effect of glycosaminoglycans on enzyme activity. J Biol Chem 271:26307-26314.
29. Serpell LC, Sunde M, and Blake CC (1997). The molecular basis of amyloidosis. Cell Mol Life Sci 53:871-877.
30. Shimizu M, Higuchi K, Bennett B, Xia C, Tsuboyama T, Kasai S, Chiba T, Fujisawa H, Kogishi K, Kitado H, Kimoto M, Takeda N, Matsushita M, Okumura H, Serikawa T, Nakamura T, Johnson TE, and Hosokawa M (1999). Identification of peak bone mass QTL in a spontaneously osteoporotic mouse strain. Mamm Genome 10:81-87.
31. Shimizu M, Higuchi K, Kasai S, Tsuboyama T, Matsushita M, Matsumura T, Okudaira S, Mori M, Koizumi A, Nakamura T, and Hosokawa M (2002). A congenic mouse and candidate gene at chromosome 13 locus regulating bone density. Mamm Genome 13:335-340.
32. Shimizu M, Higuchi K, Kasai S, Tsuboyama T, Matsushita M, Mori M, Shimizu Y, Nakamura T, and Hosokawa M (2001). Chromosome 13 locus, Pbd2, regulates bone density in mice. J Bone Miner Res 16:1972-1982.
33. Snow AD and Kisilevsky R (1985). Temporal relationship between glycosaminoglycan accumulation and amyloid deposition during experimental amyloidosis: A histochemical study. Lab Invest 53:37-44.
34. Tietge UJ, Maugeais C, Cain W, Grass D, Glick JM, de Beer FC, and Rader DJ (2000). Overexpression of secretory phospholipase A(2) causes rapid catabolism and altered tissue uptake of high density lipoprotein cholesteryl ester and apolipoprotein A-I. J Biol Chem 275:10077-10084.
35. Vadas P, Browning J, Edelson J, and Pruzanski W (1993). Extracellular phospholipase A2 expression and inflammation: The relationship with associated disease states. J Lipid Mediat 1-30.
36. Wang J, Kitagawa K, Kitado H, Kogishi K, Matsushita T, Hosokawa M, and Higuchi K (1997). Regulation of the metabolism of plasma lipoproteins by apolipoprotein A-II. Biochim Biophys Acta 1345:248-258.
37. Westermark P (1998). The pathogenesis of amyloidosis: Understanding general principles. Am J Pathol 152:1125-1127.
38. Woodrow SI, Stewart RJ, Kisifevsky R, Gore J, and Young ID (1999). Experimental AA amyloidogenesis is associated with differential expression of extracellular matrix genes. Amyloid 6:22-30.
39. Wohlgethan JR and Cathcart ES (1979). Amyloid resistance in A/J mice is determined by a single gene. Nature 278:453-454.
40. Xing Y and Higuchi K (2002). Amyloid fibril protein. Mech Ageing Dev 123:1625-1636.
41. Xing Y, Nakamura A, Korenaga T, Guo Z, Yao J, Fu X Matsushita T, Kogishi K, Hosokawa M, Kametani F, Mori M, and Higuchi K (2002). Induction of protein conformational change in mouse senile amyloidosis. J Biol Chem 277:33164-33169.